Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hims & Hers Health Inc (NY: HIMS )

17.66 +0.53 (+3.09%)
Official Closing Price Updated: 4:10 PM EDT, Oct 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Hims & Hers Health Inc

< Previous 1 2 3 4 5 Next >
bluebird bio stock is ripe for a 400% institutional short squeeze
Bluebird Bio stock could be on the verge of a 400% pop on earnings, management has set the writing on the wall for institutional buying to trickle in 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
From Hims & Hers Health, Inc.
Via Business Wire
This healthcare stock making a buzz with 160% growth
Healthcare stocks are typically on the boring side of the spectrum, that is until you add a bit of technology and the right niche to them. 
Via MarketBeat
Topics Economy
Exposures Economy
Hims & Hers Names Dan Kenger as the Company’s First Chief Design Officer
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers Health Inc. (NYSE: HIMS) is a Stock Spotlight on 5/17
Via Investor Brand Network
Hims & Hers Health Inc. (NYSE: HIMS) is a Stock Spotlight on 5/5
Via Investor Brand Network
Hims & Hers Health Inc. (NYSE: HIMS) is a Stock Spotlight on 3/29
Via Investor Brand Network
Hims & Hers to Announce Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers Teams with Hartford HealthCare to Connect People to In-person Care
From Hims & Hers Health, Inc.
Via Business Wire
Weight Watchers gains from Oprah’s GLP-1 weight-loss
Oprah Winfrey revealed she has lost over 60 pounds and is on the path to reaching her weight goal of 167 lbs. She credits this to taking GLP-1 medication 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
LifeMD expands telehealth GLP-1weight-loss service with Medifast
LifeMD Inc. (NASDAQ: LFMD) is a direct-to-consumer (DTC) comprehensive virtual healthcare platform. The company offers per-visit and membership plan pricing 
Via MarketBeat
Ozempic vs. Mounjaro:: Battle of the bulge
The year 2023 was a breakout year for glucagon-like peptide (GLP-1) weight-loss drugs, led by the popularity of Ozempic. Celebrity usage 
Via MarketBeat
Exposures Product Safety
Hims & Hers Launches Holistic Weight Loss Program to Break the Endless Cycle of Weight Gain and Loss
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers earnings highlight expanded personalized treatments
E-health and wellness platform operator Hims & Hers Inc. reported a stellar quarter of growth that highlighted its expanded line of personalized products 
Via MarketBeat
Hims & Hers Health, Inc. Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Outlook
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers Health, Inc. Announces $50 Million Share Repurchase Program Authorization
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers Introduces MedMatch, The Next Generation of Intelligent Diagnostic Services
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers Names Khobi Brooklyn As Chief Communications Officer
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers to Announce Third Quarter 2023 Financial Results on November 6, 2023
From Hims & Hers Health, Inc.
Via Business Wire
2 Beauty Stocks Beaten By the Ugly Stick But Ready to Rally
Beauty stocks have not been pretty this year. Cosmetics retailer Ulta Beauty Inc. (NASDAQ: ULTA) and Estee Lauder Co. (NYSE: EL) shares 
Via MarketBeat
Hims & Hers Named on Fortune Media and Great Place to Work’s 2023 Best Workplaces in Health Care List
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers Health, Inc. Reports Second Quarter 2023 Financial Results and Raises Full Year 2023 Outlook
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers Expands Into Cardiovascular Health with New Dual-Action Capabilities
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers to Announce Second Quarter 2023 Financial Results on August 7, 2023
From Hims & Hers Health, Inc.
Via Business Wire
Half of Women Experience Hair Loss; Hers Unveils Innovative Line of Personalized Solutions
From Hims & Hers Health, Inc.
Via Business Wire
Hard Mints Now Available Nationwide
From Hims & Hers Health, Inc.
Via Business Wire
How to Invest in Telehealth and Telemedicine Stocks
Investing in telehealth and telemedicine may boost your portfolio. Learn how to invest in telehealth and telemedicine stocks. 
Via MarketBeat
Exposures COVID-19
Hims & Hers Health, Inc. Reports First Quarter 2023 Financial Results and Raises Full Year 2023 Outlook
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers to Announce First Quarter 2023 Financial Results on May 8, 2023
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers Certified as a ‘Great Place to Work’
From Hims & Hers Health, Inc.
Via Business Wire
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.